Sodium-glucose cotransporter-2 inhibitors in obesity and associated cardiometabolic disorders: where do we stand?

N.G. Vallianou, D. Tsilingiris, D. Kounatidis, I.G. Lempesis, I. Karampela, M. Dalamaga*

*Corresponding author for this work

Research output: Contribution to journal › (Systematic) Review article › peer-review

Fingerprint

Dive into the research topics of 'Sodium-glucose cotransporter-2 inhibitors in obesity and associated cardiometabolic disorders: where do we stand?'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science